

Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
A foundation established by Silicon Valley entrepreneur Sean Parker—founder of Napster and first president of Facebook—has committed $250 million to research in cancer immunotherapy.
In Brief


Drugs & Targets
Trending Stories
- Otis Brawley looks back on a year of great science and greater challenges
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Twitter star Vinay Prasad retires @VinayPrasadMD
- AI will determine Medicare prior authorizations in six states under new pilot program
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park











